|
ETF1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.25009999998971E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.405350E-04 |
| Normal-vs-Stage2 |
3.077900E-03 |
| Normal-vs-Stage3 |
3.9702999999891E-06 |
| Normal-vs-Stage4 |
1.167280E-04 |
| Stage1-vs-Stage2 |
6.310000E-01 |
| Stage1-vs-Stage3 |
5.557900E-02 |
| Stage1-vs-Stage4 |
1.421360E-01 |
| Stage2-vs-Stage3 |
4.128800E-01 |
| Stage2-vs-Stage4 |
5.398400E-01 |
| Stage3-vs-Stage4 |
8.789000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.5081999999752E-06 |
| Normal-vs-AfricanAmerican |
4.38489999999847E-05 |
| Normal-vs-Asian |
5.198000E-02 |
| Caucasian-vs-AfricanAmerican |
1.654810E-01 |
| Caucasian-vs-Asian |
5.779400E-01 |
| AfricanAmerican-vs-Asian |
9.948800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.07019999990344E-07 |
| Normal-vs-Female |
5.825700E-04 |
| Male-vs-Female |
1.429380E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.616500E-04 |
| Normal-vs-Age(41-60Yrs) |
1.72654999999189E-05 |
| Normal-vs-Age(61-80Yrs) |
4.11270000000297E-05 |
| Normal-vs-Age(81-100Yrs) |
1.064170E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.216400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.810210E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.081400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.560800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.739200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.616400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.755840E-01 |
| Normal-vs-Grade 2 |
2.784700E-04 |
| Normal-vs-Grade 3 |
1.51768999999691E-05 |
| Normal-vs-Grade 4 |
3.94630000000173E-06 |
| Grade 1-vs-Grade 2 |
8.443800E-01 |
| Grade 1-vs-Grade 3 |
4.931800E-01 |
| Grade 1-vs-Grade 4 |
2.530000E-01 |
| Grade 2-vs-Grade 3 |
1.331040E-01 |
| Grade 2-vs-Grade 4 |
2.232400E-02 |
| Grade 3-vs-Grade 4 |
2.626400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.088470E-02 |
| Normal-vs-ccB subtype |
1.46969999947899E-07 |
| ccA subtype-vs-ccB subtype |
5.607600E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.53383000000007E-05 |
| Normal-vs-N1 |
3.094200E-02 |
| N0-vs-N1 |
8.335400E-01 |
|
|
